But buyer, beware. Cobbling together “packages” designed to cover gaps in high-deductible health plans could shortchange consumers, warn advocates.
As stopgap health plans gain attention as possible alternatives to Obamacare, consumers are advised to read the fine print.
Los promocionan como una alternativa económica a los planes de ACA. Pero expertos en mercados de seguros dudan sobre el tipo de cobertura que ofrecen.
Regulators are beginning to scrutinize claims by companies that their alternative plans help people meet Obamacare requirements.
With federal support slashed for organizations that provided consumers help in making their health plan choices, insurance brokers have to pick up the slack.
El período abierto de inscripción para las personas que compran su propio seguro de salud ya está en marcha, y termina el 15 de diciembre de 2017. Estos son cinco factores para tener en cuenta.
This year’s Obamacare open enrollment will be marked by a number of changes. KHN helps you navigate them.
Las medidas del presidente Donald Trump eliminan los reembolsos a las aseguradoras, pero no los subsidios que permiten a los consumidores pagar sus primas.
A quick guide to revisions to the cost-sharing subsidies for lower-income marketplace customers and the proposal to add different plans to the market.
But the approaches are not new and critics worry that these changes will leave some consumers with skimpier plans that expose them to high medical bills.
Both President Donald Trump and Sen. Rand Paul (R-Ky.) signaled last week that executive action was in the works that would give these plans a boost.
En la ciudad hay un solo centro de trauma, especializado en tratar a pacientes con lesiones severas producto de disparos, caídas o accidentes automovilísticos. Qué pasa a nivel nacional
Hospitals view adding trauma care as a potential profit tool, but experts say having more centers does not necessarily improve the system’s ability to respond to a mass casualty event.
The fate of the Affordable Care Act’s individual insurance marketplaces remains in play as state insurance commissioners take a central role in the debate.
The FDA granted approval for Spinraza in late December for use on children and adults with spinal muscular atrophy. Insurance coverage is mostly focused on infants and children.
The high cost of Spinraza, a new and promising treatment for spinal muscular atrophy, highlights how the cost-benefit analysis insurers use to make drug coverage decisions plays out in human terms.
Republican senators are warming to the idea of a scaled-back plan that would delete the Affordable Care Act’s individual and employer mandates but leave the rest of law generally intact. But this approach has caused difficulties in the past.
During another day of fast-moving developments, Senate Republicans signaled their intent to attempt to bring an updated repeal-and-delay bill to the floor for a vote next week.
The failure this week of the U.S. Senate’s ACA repeal effort was one more twist in the ongoing political drama that has complicated routine rate setting for insurers and state officials.
A key bill provision would likely lower premiums, but coverage would be skimpier with consumers left to figure out the trade-offs.